The program, launched last year, is designed to help early-career investigators who have primarily worked within groups pursuing independent research.
Investigators saw signs that risky TP53 missense mutations may interfere with wild type copies of the tumor suppressor gene in acute myeloid leukemia and other myeloid cancers.
Vertex Pharmaceuticals has invested £10.5 million in the British analytics company as the companies launch a multiyear R&D partnership seeking novel drug targets.
The grants are designed to help investigators working within groups pursue independent research and advance their careers in genomic science.
Researchers at the annual Association of Biomolecular Resource Facilities meeting said they are joining single-cell sequencing to other single-cell analyses.
The partners plan to share information about joint R&D activities and establish research facilities and laboratory infrastructure in Ethiopia.
The bill aims to reduce barriers to the use of genetic and genomic testing, including for children on Medicaid with a suspected genetic disease.
The institute expects to announce its strategic plan in October 2020 to commemorate the 30th anniversary of the launch of the Human Genome Project.
Areas of concern are the recruitment of talented scientists, as well as retaining access to EU funding, European research collaborations, and clinical trials.
The agency aims to fund projects examining the ethical, legal, and social implications of human genome research.
A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.
Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.
The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.
In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.